Fig. 2
From: L-arginine dependence of breast cancer – molecular subtypes matter.
Receiver-operated curve (ROC) analysis of biomarkers related to mortality and recurrence of breast cancer. a) ADMA and total mortality in patients with Luminal A breast cancer; b) ADMA and recurrent disease in patients with Luminal A breast cancer; c) L-citrulline and total mortality in patients with triple-negative breast cancer; d) L-citrulline and recurrent disease in patients with triple-negative breast cancer. The arrows point to the optimal cut-off values to differentiate between survivors and non-survivors (a and c) and patients with or without recurrent disease (b and d)